<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-27T21:44:18Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/71462" metadataPrefix="etdms">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/71462</identifier><datestamp>2026-04-09T10:20:23Z</datestamp><setSpec>com_10324_1138</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1226</setSpec></header><metadata><thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.0/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
<title>Programmed Cell Death and Autophagy in an in vitro Model of Spontaneous Neuroretinal Degeneration</title>
<creator>Puertas Neyra, Kevin Louis</creator>
<creator>Galindo Cabello, Nadia Regina</creator>
<creator>Hernández Rodríguez, Leticia Adriána</creator>
<creator>González Pérez, Fernando</creator>
<creator>Rodríguez Cabello, José Carlos</creator>
<creator>González  Sarmiento, Rogelio</creator>
<creator>Pastor Jimeno, José Carlos</creator>
<creator>Usategui Martín, Ricardo</creator>
<creator>Fernández Bueno, Iván</creator>
<description>Producción Científica</description>
<description>Retinal neurodegenerative diseases are the leading causes of visual impairment and&#xd;
irreversible blindness worldwide. Although the retinal response to injury remains closely&#xd;
similar between different retinal neurodegenerative diseases, available therapeutic&#xd;
alternatives are only palliative, too expensive, or very specific, such as gene therapy.&#xd;
In that sense, the development of broad-spectrum neuroprotective therapies seems&#xd;
to be an excellent option. In this regard, it is essential to identify molecular targets&#xd;
involved in retinal degeneration, such as cell death mechanisms. Apoptosis has been&#xd;
considered as the primary cell death mechanism during retinal degeneration; however,&#xd;
recent studies have demonstrated that the only use of anti-apoptotic drugs is not&#xd;
enough to confer good neuroprotection in terms of cell viability and preservation. For&#xd;
that reason, the interrelationship that exists between apoptosis and other cell death&#xd;
mechanisms needs to be characterized deeply to design future therapeutic options that&#xd;
simultaneously block the main cell death pathways. In that sense, the study aimed&#xd;
to characterize the programmed cell death (in terms of apoptosis and necroptosis)&#xd;
and autophagy response and modulation in retinal neurodegenerative diseases, using&#xd;
an in vitro model of spontaneous retinal neurodegeneration. For that purpose, we&#xd;
measured the mRNA relative expression through qPCR of a selected pool of genes&#xd;
involved in apoptosis (BAX, BCL2, CASP3, CASP8, and CASP9), necroptosis (MLKL,&#xd;
RIPK1, and RIPK3), and autophagy (ATG7, BCLIN1, LC3B, mTOR, and SQSTM1);&#xd;
besides, the immunoexpression of their encoding proteins (Casp3, MLKL, RIPK1,&#xd;
LC3B, and p62) were analyzed using immunohistochemistry. Our results showed&#xd;
an increase of pro-apoptotic and pro-necroptotic related genes and proteins during&#xd;
in vitro retinal neurodegeneration. Besides, we describe for the first time the modulation between programmed cell death mechanisms and autophagy in an in vitro retinal&#xd;
neurodegeneration model. This study reinforces the idea that cell death mechanisms&#xd;
are closely interconnected and provides new information about molecular signaling and&#xd;
autophagy along the retinal degeneration process.</description>
<date>2024-11-14</date>
<date>2024-11-14</date>
<date>2022</date>
<type>info:eu-repo/semantics/article</type>
<identifier>Frontiers in Neuroanatomy 2022;16:812487</identifier>
<identifier>https://uvadoc.uva.es/handle/10324/71462</identifier>
<identifier>10.3389/fnana.2022.812487</identifier>
<identifier>Frontiers in Neuroanatomy</identifier>
<identifier>16</identifier>
<identifier>1662-5129</identifier>
<language>eng</language>
<rights>info:eu-repo/semantics/openAccess</rights>
<rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</rights>
<rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</rights>
</thesis></metadata></record></GetRecord></OAI-PMH>